Related Experiment Videos
Relationship between response and survival in patients with advanced ovarian cancer
Journal of the National Cancer Institute
|June 3, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The importance of mRNA structure in determining the pathogenicity of synonymous and non-synonymous mutations in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia·2016
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study.
European journal of clinical nutrition·2013
Associations between food patterns defined by cluster analysis and colorectal cancer incidence in the NIH-AARP diet and health study.
European journal of clinical nutrition·2008
OPEN about obesity: recovery biomarkers, dietary reporting errors and BMI.
International journal of obesity (2005)·2007
SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.
Journal of the National Cancer Institute·2026
PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.
Journal of the National Cancer Institute·2026
Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.
Journal of the National Cancer Institute·2026
Treatment Effect Discrepancy Between PFS and OS in Antibody-Drug Conjugate Trials for Metastatic Breast Cancer: A Meta-Epidemiologic Analysis.
Journal of the National Cancer Institute·2026
Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.
Journal of the National Cancer Institute·2026
(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.
Journal of the National Cancer Institute·2026
Hypoxia-Induced Expression of miR-424, miR-155, CD47, and PD-L1 in a Gastric Cancer Cell Line (MKN-45).
Iranian biomedical journal·2026
Long-term safety of first-line osimertinib plus platinum-pemetrexed in EGFR-mutated advanced NSCLC: FLAURA2.
Lung cancer (Amsterdam, Netherlands)·2026